Maze Therapeutics Inc.

NASDAQ: MAZE · Real-Time Price · USD
13.49
0.14 (1.05%)
At close: Aug 15, 2025, 3:59 PM
13.50
0.07%
After-hours: Aug 15, 2025, 05:38 PM EDT

Maze Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q4 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Dec 31, 2023
Cash & Equivalents
264.54M 294.37M 196.81M 149.61M 175.06M 29.16M
Short-Term Investments
n/a n/a n/a n/a n/a n/a
Long-Term Investments
1.09M 1.09M 1.09M 1.09M n/a 1.09M
Other Long-Term Assets
3.57M 3.25M 7.87M 6.5M 4.23M 1.32M
Receivables
n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
6.61M 5.33M 4.86M 4.35M 4.33M 4.95M
Total Current Assets
271.15M 299.71M 201.67M 153.96M 179.4M 34.11M
Property-Plant & Equipment
27.71M 28.8M 29.92M 30.93M 32.16M 34.98M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
32.37M 33.13M 38.87M 38.52M 36.4M 37.39M
Total Assets
303.52M 332.84M 240.54M 192.48M 215.79M 71.5M
Account Payables
3.67M 2.4M 1.94M 1.02M 2.18M 2.02M
Deferred Revenue
n/a n/a n/a n/a 2.5M n/a
Short-Term Debt
4.72M 4.67M 4.63M 4.62M n/a 4.49M
Other Current Liabilities
5.84M -400K 3.45M 1.6M 4.47M 2.39M
Total Current Liabilities
19.9M 18.62M 20.67M 17.55M 21.61M 16.32M
Long-Term Debt
20.29M n/a 22M 51.75M 49.1M 20.08M
Other Long-Term Liabilities
1.09M 1.01M 509.06M 384.91M 383.9M 383.9M
Total Long-Term Liabilities
21.38M 22.16M 531.05M 459.46M 456.56M 429.04M
Total Liabilities
41.28M 40.77M 551.73M 477.01M 478.17M 445.35M
Total Debt
25.01M 25.82M 26.63M 79.16M 77.23M 49.62M
Common Stock
44K 44K 2K 2K 23K 2K
Retained Earnings
-424.89M -391.21M -358.43M -313.88M -289.12M -395.69M
Comprehensive Income
n/a n/a n/a n/a n/a n/a
Shareholders Equity
262.24M 292.07M -311.18M -284.53M -262.37M -373.85M
Total Investments
1.09M 1.09M 1.09M 1.09M n/a 1.09M